Skip to Content

TEVA 7389 (Risedronate Sodium 35 mg)

Pill with imprint TEVA 7389 is Orange, Round and has been identified as Risedronate Sodium 35 mg. It is supplied by Teva Pharmaceuticals USA Inc..

Risedronate is used in the treatment of osteoporosis; paget's disease; prevention of osteoporosis and belongs to the drug class bisphosphonates. Risk cannot be ruled out during pregnancy. Risedronate 35 mg is not a controlled substance under the Controlled Substances Act (CSA).

Images for TEVA 7389

Risedronate sodium 35 mg TEVA 7389
Risedronate sodium 35 mg TEVA 7389
Risedronate sodium 35 mg TEVA 7389 Front
Risedronate sodium 35 mg TEVA 7389 Back
Risedronate sodium 35 mg TEVA 7389

Risedronate Sodium

Imprint:
TEVA 7389
Strength:
35 mg
Color:
Orange
Shape:
Round
Availability:
Prescription only
Drug Class:
Bisphosphonates
Pregnancy Category:
C - Risk cannot be ruled out
CSA Schedule:
Not a controlled drug
Labeler / Supplier:
Teva Pharmaceuticals USA Inc.
National Drug Code (NDC):
00093-3098

Get help with Imprint Code FAQs.

Further information

Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.

Hide